Advancements in the Alcohol-Associated Liver Disease Model

Biomolecules. 2022 Jul 27;12(8):1035. doi: 10.3390/biom12081035.

Abstract

Alcohol-associated liver disease (ALD) is an intricate disease that results in a broad spectrum of liver damage. The presentation of ALD can include simple steatosis, steatohepatitis, liver fibrosis, cirrhosis, and even hepatocellular carcinoma (HCC). Effective prevention and treatment strategies are urgently required for ALD patients. In previous decades, numerous rodent models were established to investigate the mechanisms of alcohol-associated liver disease and explore therapeutic targets. This review provides a summary of the latest developments in rodent models, including those that involve EtOH administration, which will help us to understand the characteristics and causes of ALD at different stages. In addition, we discuss the pathogenesis of ALD and summarize the existing in vitro models. We analyse the pros and cons of these models and their translational relevance and summarize the insights that have been gained regarding the mechanisms of alcoholic liver injury.

Keywords: alcohol; alcohol-associated liver disease; in vitro model; in vivo model; pathological processes.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular* / pathology
  • Ethanol / toxicity
  • Humans
  • Liver / pathology
  • Liver Diseases, Alcoholic* / pathology
  • Liver Neoplasms* / pathology

Substances

  • Ethanol

Grants and funding

This research was funded by the National Science Foundation of China (U19A2001,81970534,82070628); Research Fund of AnHui Institute of translational medicine (No. 2021zhyx-B06) and the funds from the University Synergy Innovation Program of Anhui Province (GXXT-2020-063, GXXT-2020-025).